KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Account Payables: 2013-2025

Historic Change in Account Payables for Ionis Pharmaceuticals (IONS) over the last 13 years, with Sep 2025 value amounting to -$8.8 million.

  • Ionis Pharmaceuticals' Change in Account Payables fell 309.44% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 345.75%. This contributed to the annual value of $16.0 million for FY2024, which is 96.95% up from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Change in Account Payables stood at -$8.8 million for Q3 2025, which was up 56.83% from -$20.4 million recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Change in Account Payables peaked at $35.2 million during Q4 2024, and registered a low of -$20.4 million during Q2 2025.
  • For the 3-year period, Ionis Pharmaceuticals' Change in Account Payables averaged around -$455,182, with its median value being -$2.2 million (2024).
  • Per our database at Business Quant, Ionis Pharmaceuticals' Change in Account Payables plummeted by 2,428.22% in 2021 and then skyrocketed by 556.04% in 2023.
  • Quarterly analysis of 5 years shows Ionis Pharmaceuticals' Change in Account Payables stood at $4.7 million in 2021, then plummeted by 195.27% to -$4.5 million in 2022, then skyrocketed by 556.04% to $20.6 million in 2023, then soared by 71.06% to $35.2 million in 2024, then plummeted by 309.44% to -$8.8 million in 2025.
  • Its last three reported values are -$8.8 million in Q3 2025, -$20.4 million for Q2 2025, and $92,000 during Q1 2025.